HTG Molecular Diagnostics, Inc. provided revenue guidance for the full year 2022. The company expects revenue to build throughout the remainder of 2022, resulting in full year 2022 revenue, reflecting robust growth over 2021. Of course, this assumes company don't experience any negative or sustained downturn in sales cycles as a result of the pandemic or broader global economic issues.